Delivery Order SPE2DR25D3109-SPE2DR26FT2GZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,479.42 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a joint care injection medication. This firm fixed-price contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $30,759.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Synvisc-One syringes (6 milliliters, 1 pack) with an ultimate completion date of November 19, 2025. This is a non-set-aside, competitively awarded contract supporting the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a $13,303.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One syringes (6mL) on September 15, 2025, with an ultimate completion date of September 16, 2025. The award, which carries no set-aside designation, represents a competitive procurement fulfilled by the pharmaceutical distributor from its Conshohocken, Pennsylvania corporate office. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $30,813.16 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a pharmaceutical product for joint pain management. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Synvisc-One Syringe 6ML, a pharmaceutical product used in joint pain management. This is a firm fixed price delivery order with a ceiling value of $17,220.22 and an ultimate completion date of September 17, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,398.41 on July 29, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,710.14 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis pain management. The contract, issued on December 2, 2025, with completion scheduled for December 3, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation, for the supply of Synvisc-One syringe 6 ml. The contract has a potential value of $1,605.08 and a completion date of March 1, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA with a potential value of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $12,194.04 on November 6, 2025, for the supply of Synvisc-One Syringe 6ML, a viscosupplementation medication used in joint pain management. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract was competitively awarded with no...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This is a firm fixed price delivery order with a ceiling value of $6,009.24 and an ultimate completion date of July 2, 2025. The contract represents a non-competitive award utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- SPE2DR25D3109Indefinite Delivery Contract
- SPE2DR25D3109-SPE2DR26FT2GZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $10,137.85 to supply Synvisc-One Syringe 6ML, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that serves military and veteran healthcare systems through its extensive portfolio of medical product deliveries. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC, designated SPE2DX, functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and specialized medical devices. The award reflects the contractor's demonstrated capability to meet federal procurement requirements and support the Defense Health Agency and other government healthcare systems through a flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 12/3/25 |